Fig. 3From: Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patientsForest plots showing the results of meta-analyses for primary outcomes. A Mortality, B Progression to severe disease, C Negative RT-PCR. Forest plots showing the results of meta-analyses for secondary outcomes. D Recovery, E Duration of hospitalization, F Time to negative RT-PCR, and G Viral loadBack to article page